학술논문
Progression-free survival by investigator versus blinded independent central review in newly diagnosed patients with high-grade serous ovarian cancer: Analysis of the VELIA/GOG-3005 trial
Document Type
Article
Author
Source
In Gynecologic Oncology August 2021 162(2):375-381
Subject
Language
ISSN
0090-8258